Source: Arthritis Research & Therapy. Unidade: ICB
Subjects: IMUNOLOGIA, NEUTRÓFILOS, PLASMA, PLAQUETAS SANGUÍNEAS, EXPLOSÃO RESPIRATÓRIA, CITOMETRIA DE FLUXO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERAZZIO, Sandro Félix et al. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease. Arthritis Research & Therapy, v. 19, n. 1, p. 235 (1-15), 2017Tradução . . Disponível em: https://doi.org/10.1186/s13075-017-1443-5. Acesso em: 30 set. 2024.APA
Perazzio, S. F., Soeiro-Pereira, P. V., Santos, V. C. dos, Brito, M. V. de, Salu, B., Oliva, M. L. V., et al. (2017). Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease. Arthritis Research & Therapy, 19( 1), 235 (1-15). doi:10.1186/s13075-017-1443-5NLM
Perazzio SF, Soeiro-Pereira PV, Santos VC dos, Brito MV de, Salu B, Oliva MLV, Stevens AM, Souza AWS de, Ochs HD, Torgerson TR, Condino Neto A, Andrade LEC. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease [Internet]. Arthritis Research & Therapy. 2017 ; 19( 1): 235 (1-15).[citado 2024 set. 30 ] Available from: https://doi.org/10.1186/s13075-017-1443-5Vancouver
Perazzio SF, Soeiro-Pereira PV, Santos VC dos, Brito MV de, Salu B, Oliva MLV, Stevens AM, Souza AWS de, Ochs HD, Torgerson TR, Condino Neto A, Andrade LEC. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease [Internet]. Arthritis Research & Therapy. 2017 ; 19( 1): 235 (1-15).[citado 2024 set. 30 ] Available from: https://doi.org/10.1186/s13075-017-1443-5